Skip to content

effect of 5-fu and rosemary extract polymeric wound dressing

A Comparative study of the effect of nanofibers containing 5% 5-Fluorouracil and rosemary extract and nanofibers containing 5% 5-Fluorouracil and 5% 5-Fluorouracil cream on Actinic Keratosis Lesions Treatment

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT20210118050067N1
Enrollment
15
Registered
2021-02-16
Start date
2021-02-19
Completion date
Unknown
Last updated
2021-07-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Actinic keratosis. Actinic keratosis

Interventions

Intervention 1: Control group: Patients take 5% 5-fluorouracil cream from Meda Co. They take the cream every night until the next morning for 4 weeks. Intervention 2: Intervention group: Patients take

Sponsors

Esfahan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Clinical diagnosis of actinic keratosis at least 18 years old consent of the individual to participate in the study

Exclusion criteria

Exclusion criteria: Previous history of allergy to formulation ingredients pregnant or lactating mothers patients on immunosuppressive, immunomodulatory, cytotoxic, and systemic steroid drugs patients who received treatment for their lesions in the 4 weeks preceding the study patients with lip lesions (because of prevention of changing into Squamous cell carcinoma)

Design outcomes

Primary

MeasureTime frame
Treatment of cutaneous lesions. Timepoint: at the beginning and after 6 weeks. Method of measurement: Global improvement score.;Patient satisfaction. Timepoint: 6 weeks after starting the use of nanofibers and Fluorouracil cream. Method of measurement: Visual Analogue Scale Score.

Secondary

MeasureTime frame
Adverse effects. Timepoint: 6 weeks after starting the use of nanofibers and Fluorouracil cream. Method of measurement: Ask the patient and Physical examination.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactNazila Poostiyan

Esfahan University of Medical Sciences

n.poostiyan@med.mui.ac.ir+98 31 1668 5555

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026